Owners, management and financials
CVR: 26027322
Secondary names: Dan DenDrit ApS, DanDrit ApS, DanDrit Biotech ApS
Previous names: A/S PSE NR. 5697, DANDRIT BIOTECH A/S, DanDrit Biotech ApS
DKK -4,478
Gross profit
Net result: DKK -1,178,038
Lunai Bioworks Inc. (100%)
CVR · view owners
David Hershel Weinstein
CVR · view management
Active
Founded 1 April 2001
CVR · view overview
1 employee
CVR · 2017
Director role ended: Francois Binette
CVR · 17/12/2024
View the full event history
Renovaro Biosciences Denmark ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2001. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Enochian BioSciences Denmark ApS and DanDrit Biotech ApS. The management consists of David Hershel Weinstein. The company is owned by Lunai Bioworks Inc.. The company has 1 employee (2017). In 2026, the company reported a gross profit of DKK -4,478 and a net result of DKK -1,178,038 compared with DKK -4,629,959 the year before. Equity in the 2026 report amounted to DKK -91,933,986.
Selskabets formål er at drive forskning, handel, fabrikation og dermed beslægtet virksomhed primært inden for medicinalbranchen.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202601/07/2025 – 30/06/2026 | -4 t. | -1.2 mio. | 0 | -91.9 mio. | 0 | |
| 202501/07/2024 – 30/06/2025 | -5 t. | -4.6 mio. | 13 t. | -90.8 mio. | 0 | |
| 202401/07/2023 – 30/06/2024 | -80 t. | -6.2 mio. | 1.4 mio. | -86.1 mio. | 2 | |
| 202301/07/2022 – 30/06/2023 | -1.2 mio. | -2.2 mio. | 1.5 mio. | -79.9 mio. | 2 | |
| 202201/07/2021 – 30/06/2022 | -211 t. | -10.3 mio. | 1.3 mio. | -77.7 mio. | 1 | |
| 202101/07/2020 – 30/06/2021 | -365 t. | -3.1 mio. | 2.1 mio. | -67.5 mio. | 1 | |
| 202001/07/2019 – 30/06/2020 | -1.1 mio. | -1.7 mio. | 5.7 mio. | -64.3 mio. | 1 | |
| 201901/07/2018 – 30/06/2019 | -1.9 mio. | -6.8 mio. | 39.4 mio. | -62.6 mio. | 1 | |
| 201801/07/2017 – 30/06/2018 | -4.5 mio. | -7 mio. | 3.1 mio. | -55.8 mio. | - | |
| 201601/01/2016 – 31/12/2016 | -5 mio. | -10.7 mio. | 5.3 mio. | -52 mio. | 2 | |
| 201501/01/2015 – 31/12/2015 | -17.4 mio. | -20.4 mio. | 8.8 mio. | -41.3 mio. | - | |
| 201401/01/2014 – 31/12/2014 | -8.5 mio. | -11.5 mio. | 2.9 mio. | -21 mio. | - | |
| 201301/01/2013 – 31/12/2013 | -5.6 mio. | -10.6 mio. | 2.1 mio. | -9.5 mio. | - |
Compared to 1.040 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreThe CVR number of Renovaro Biosciences Denmark ApS is 26027322.
Renovaro Biosciences Denmark ApS is owned by Lunai Bioworks Inc..
The management of Renovaro Biosciences Denmark ApS consists of David Hershel Weinstein.
In 2026, Renovaro Biosciences Denmark ApS reported a gross profit of DKK -4,478.
Renovaro Biosciences Denmark ApS had 1 employee in 2017 according to the Danish CVR register.
Renovaro Biosciences Denmark ApS was founded on 1 April 2001.
Claim this page to add your logo and social links. Free to get started.
Renovaro Biosciences Denmark ApS has published its annual report for 2026. Gross profit came to DKK -4,478, and the net result was DKK -1,178,038.
Renovaro Biosciences Denmark ApS has published its annual report for 2025. Gross profit came to DKK -4,596, and the net result was DKK -4,629,959.
As of August 28, 2025, CROWE STATSAUTORISERET REVISIONSINTERESSENTSKAB has been appointed auditor of Renovaro Biosciences Denmark ApS.
As of August 28, 2025, REVISION SJÆLLAND GODKENDT REVISIONSAKTIESELSKAB has stepped down as auditor of Renovaro Biosciences Denmark ApS.
Renovaro Biosciences Denmark ApS has published its annual report for 2024. Gross profit came to DKK -80,136, and the net result was DKK -6,218,232.
As of December 17, 2024, David Hershel Weinstein is registered as director of Renovaro Biosciences Denmark ApS.
As of December 17, 2024, Francois Binette has stepped down as adm. dir. of Renovaro Biosciences Denmark ApS.
Renovaro Biosciences Denmark ApS has published its annual report for 2023. Gross profit came to DKK -1,200,501, and the net result was DKK -2,163,139.
On August 8, 2023, the company changed its name from Enochian BioSciences Denmark ApS to Renovaro Biosciences Denmark ApS.
As of November 14, 2022, Francois Binette is registered as adm. dir. of Renovaro Biosciences Denmark ApS.
As of November 14, 2022, Henrik Grønfeldt-Sørensen has stepped down as adm. dir. of Renovaro Biosciences Denmark ApS.
Renovaro Biosciences Denmark ApS has published its annual report for 2022. Gross profit came to DKK -211,282, and the net result was DKK -10,264,002.
Renovaro Biosciences Denmark ApS has published its annual report for 2021. Gross profit came to DKK -365,261, and the net result was DKK -3,133,896.
Renovaro Biosciences Denmark ApS has published its annual report for 2020. Gross profit came to DKK -1,113,727, and the net result was DKK -1,708,076.
Renovaro Biosciences Denmark ApS has published its annual report for 2019. Gross profit came to DKK -1,927,253, and the net result was DKK -6,845,472.
Renovaro Biosciences Denmark ApS has published its annual report for 2018. Gross profit came to DKK -4,470,967, and the net result was DKK -7,012,131.
As of November 15, 2018, Henrik Grønfeldt-Sørensen is registered as adm. dir. of Renovaro Biosciences Denmark ApS.
As of November 15, 2018, Eric Jean Marie Leire has stepped down as adm. dir. of Renovaro Biosciences Denmark ApS.
On November 15, 2018, the company changed its name from DanDrit Biotech ApS to Enochian BioSciences Denmark ApS.
As of April 1, 2018, Henrik Grønfeldt-Sørensen has left the board of directors of Renovaro Biosciences Denmark ApS.
As of April 1, 2018, Torben Bjørn Christensen has left the board of directors of Renovaro Biosciences Denmark ApS.
As of April 1, 2018, Eric Jean Marie Leire has left the board of directors of Renovaro Biosciences Denmark ApS.
On April 1, 2018, the company changed its name from DANDRIT BIOTECH A/S to DanDrit Biotech ApS.
Renovaro Biosciences Denmark ApS has published its interim report for the period January 1, 2017 – June 30, 2017.
As of October 19, 2017, REVISION SJÆLLAND GODKENDT REVISIONSAKTIESELSKAB has been appointed auditor of Renovaro Biosciences Denmark ApS.
As of October 19, 2017, SDR2 Finance & Consult has stepped down as auditor of Renovaro Biosciences Denmark ApS.
As of October 3, 2017, SDR2 Finance & Consult has been appointed auditor of Renovaro Biosciences Denmark ApS.
As of October 3, 2017, CROWE STATSAUTORISERET REVISIONSINTERESSENTSKAB has stepped down as auditor of Renovaro Biosciences Denmark ApS.
As of July 4, 2017, Henrik Grønfeldt-Sørensen has joined the board of directors of Renovaro Biosciences Denmark ApS.
As of July 4, 2017, Torben Bjørn Christensen has joined the board of directors of Renovaro Biosciences Denmark ApS.
As of July 4, 2017, Eric Jean Marie Leire has joined the board of directors of Renovaro Biosciences Denmark ApS.
As of June 23, 2017, Niels Erik Nielsen has left the board of directors of Renovaro Biosciences Denmark ApS.
As of June 23, 2017, Aldo Michael Noes Petersen has left the board of directors of Renovaro Biosciences Denmark ApS.
Renovaro Biosciences Denmark ApS has published its annual report for 2016. Gross profit came to DKK -4,965,331, and the net result was DKK -10,661,607.
Renovaro Biosciences Denmark ApS has published its annual report for 2015. Gross profit came to DKK -17,425,853, and the net result was DKK -20,352,670.
As of June 26, 2016, Jacob Rosenberg has left the board of directors of Renovaro Biosciences Denmark ApS.
Renovaro Biosciences Denmark ApS has published its annual report for 2014. Gross profit came to DKK -8,457,022, and the net result was DKK -11,472,661.
Renovaro Biosciences Denmark ApS has published its annual report for 2013. Gross profit came to DKK -5,558,844, and the net result was DKK -10,561,248.
As of February 12, 2014, is registered as an owner of Renovaro Biosciences Denmark ApS with an ownership share of 100%.
As of September 6, 2013, CROWE STATSAUTORISERET REVISIONSINTERESSENTSKAB has been appointed auditor of Renovaro Biosciences Denmark ApS.
As of September 6, 2013, Beierholm Godkendt Revisionspartnerselskab has stepped down as auditor of Renovaro Biosciences Denmark ApS.
Renovaro Biosciences Denmark ApS has published its annual report for 2012.
As of June 19, 2013, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of Renovaro Biosciences Denmark ApS.
As of June 19, 2013, BAAGØE SCHOU STATSAUTORISERET REVISIONSAKTIESELSKAB has stepped down as auditor of Renovaro Biosciences Denmark ApS.
As of June 19, 2013, Niels Erik Nielsen has joined the board of directors of Renovaro Biosciences Denmark ApS.
As of June 19, 2013, Jacob Rosenberg has joined the board of directors of Renovaro Biosciences Denmark ApS.
As of June 19, 2013, Aldo Michael Noes Petersen has joined the board of directors of Renovaro Biosciences Denmark ApS.
As of June 19, 2013, Knud Carsten Bernhard Lønfeldt has left the board of directors of Renovaro Biosciences Denmark ApS.
As of June 19, 2013, Peter Buhl has left the board of directors of Renovaro Biosciences Denmark ApS.
As of June 19, 2013, Sune Olsen has left the board of directors of Renovaro Biosciences Denmark ApS.
As of February 25, 2013, BAAGØE SCHOU STATSAUTORISERET REVISIONSAKTIESELSKAB has been appointed auditor of Renovaro Biosciences Denmark ApS.
As of January 11, 2013, M.R. Tongtis Tongyai has left the board of directors of Renovaro Biosciences Denmark ApS.
As of January 1, 2013, Jacob Rosenberg has left the board of directors of Renovaro Biosciences Denmark ApS.
As of December 14, 2012, JUT NR. 2180 A/S has stepped down as auditor of Renovaro Biosciences Denmark ApS.
As of February 27, 2012, JUT NR. 2180 A/S has been appointed auditor of Renovaro Biosciences Denmark ApS.
As of February 27, 2012, BAAGØE SCHOU STATSAUTORISERET REVISIONSAKTIESELSKAB has stepped down as auditor of Renovaro Biosciences Denmark ApS.
As of February 27, 2012, Jacob Rosenberg has joined the board of directors of Renovaro Biosciences Denmark ApS.
As of February 27, 2012, Knud Carsten Bernhard Lønfeldt has joined the board of directors of Renovaro Biosciences Denmark ApS.
As of February 27, 2012, Peter Buhl has joined the board of directors of Renovaro Biosciences Denmark ApS.
As of February 27, 2012, Sune Olsen has joined the board of directors of Renovaro Biosciences Denmark ApS.
As of February 27, 2012, M.R. Tongtis Tongyai has joined the board of directors of Renovaro Biosciences Denmark ApS.
As of February 27, 2012, Peter Brincker Møller has left the board of directors of Renovaro Biosciences Denmark ApS.
As of February 27, 2012, Dina Asmussen has left the board of directors of Renovaro Biosciences Denmark ApS.
As of February 27, 2012, Eric Jean Marie Leire has left the board of directors of Renovaro Biosciences Denmark ApS.
As of June 21, 2011, Paul Laursen has left the board of directors of Renovaro Biosciences Denmark ApS.
As of January 13, 2011, Peter Brincker Møller has joined the board of directors of Renovaro Biosciences Denmark ApS.
As of January 1, 2011, Eric Jean Marie Leire is registered as adm. dir. of Renovaro Biosciences Denmark ApS.
As of December 31, 2010, Mai-Britt Zocca has stepped down as adm. dir. of Renovaro Biosciences Denmark ApS.
As of September 20, 2010, Paul Laursen has joined the board of directors of Renovaro Biosciences Denmark ApS.
As of September 20, 2010, Ulrik Finnemann has left the board of directors of Renovaro Biosciences Denmark ApS.
As of August 18, 2010, Jacob Rosenberg has left the board of directors of Renovaro Biosciences Denmark ApS.
As of July 8, 2010, Jacob Rosenberg has joined the board of directors of Renovaro Biosciences Denmark ApS.
As of July 6, 2010, Mogens Helweg Claesson has left the board of directors of Renovaro Biosciences Denmark ApS.
As of March 12, 2010, Dina Asmussen has joined the board of directors of Renovaro Biosciences Denmark ApS.
As of March 12, 2010, Eric Jean Marie Leire has joined the board of directors of Renovaro Biosciences Denmark ApS.
As of March 9, 2010, Jesper Zeuthen has left the board of directors of Renovaro Biosciences Denmark ApS.
As of September 3, 2009, Jacob Rosenberg has left the board of directors of Renovaro Biosciences Denmark ApS.
As of March 6, 2009, Jacob Rosenberg has joined the board of directors of Renovaro Biosciences Denmark ApS.
As of March 6, 2009, Jesper Zeuthen has joined the board of directors of Renovaro Biosciences Denmark ApS.
As of March 6, 2009, Kaare Fiala has left the board of directors of Renovaro Biosciences Denmark ApS.
As of June 25, 2007, Mai-Britt Zocca is registered as adm. dir. of Renovaro Biosciences Denmark ApS.
As of June 25, 2007, Dina Asmussen has stepped down as adm. dir. of Renovaro Biosciences Denmark ApS.
As of June 15, 2007, BAAGØE SCHOU STATSAUTORISERET REVISIONSAKTIESELSKAB has been appointed auditor of Renovaro Biosciences Denmark ApS.
As of June 15, 2007, Vanløse Revision v/Jannik Hansen , Statsaut.Revisor has stepped down as auditor of Renovaro Biosciences Denmark ApS.
As of June 11, 2007, Ulrik Finnemann has joined the board of directors of Renovaro Biosciences Denmark ApS.
As of May 31, 2005, Kaare Fiala has joined the board of directors of Renovaro Biosciences Denmark ApS.
As of May 31, 2005, Angela Rossetti has left the board of directors of Renovaro Biosciences Denmark ApS.
As of November 22, 2004, Vanløse Revision v/Jannik Hansen , Statsaut.Revisor has been appointed auditor of Renovaro Biosciences Denmark ApS.
As of November 22, 2004, Kristian Henning Pryds has stepped down as auditor of Renovaro Biosciences Denmark ApS.
As of May 24, 2004, Angela Rossetti has joined the board of directors of Renovaro Biosciences Denmark ApS.
As of May 24, 2004, Mogens Trygve Lied Flagstad has left the board of directors of Renovaro Biosciences Denmark ApS.
As of May 24, 2004, Suzanne Flagstad has left the board of directors of Renovaro Biosciences Denmark ApS.
As of March 1, 2004, Dina Asmussen is registered as adm. dir. of Renovaro Biosciences Denmark ApS.
As of March 1, 2004, Suzanne Flagstad has stepped down as adm. dir. of Renovaro Biosciences Denmark ApS.
As of November 4, 2003, Kristian Henning Pryds has been appointed auditor of Renovaro Biosciences Denmark ApS.
As of November 4, 2003, Mogens Trygve Lied Flagstad has joined the board of directors of Renovaro Biosciences Denmark ApS.
As of November 4, 2003, Suzanne Flagstad has joined the board of directors of Renovaro Biosciences Denmark ApS.
As of November 4, 2003, Mogens Helweg Claesson has joined the board of directors of Renovaro Biosciences Denmark ApS.
As of November 4, 2003, Suzanne Flagstad is registered as adm. dir. of Renovaro Biosciences Denmark ApS.
As of September 16, 2003, REVISIONSKONTORET I AARHUS, AKTIESELSKAB has stepped down as auditor of Renovaro Biosciences Denmark ApS.
As of September 16, 2003, Mogens Trygve Lied Flagstad has left the board of directors of Renovaro Biosciences Denmark ApS.
As of September 16, 2003, Henrik Irgang Elsner has left the board of directors of Renovaro Biosciences Denmark ApS.
As of September 16, 2003, Mogens Helweg Claesson has left the board of directors of Renovaro Biosciences Denmark ApS.
As of September 16, 2003, Suzanne Flagstad has stepped down as director of Renovaro Biosciences Denmark ApS.
As of August 4, 2003, John René Frederiksen has left the board of directors of Renovaro Biosciences Denmark ApS.
As of July 3, 2003, John René Frederiksen has joined the board of directors of Renovaro Biosciences Denmark ApS.
As of July 3, 2003, Henrik Irgang Elsner has joined the board of directors of Renovaro Biosciences Denmark ApS.
As of June 3, 2003, Mogens Helweg Claesson has joined the board of directors of Renovaro Biosciences Denmark ApS.
As of May 27, 2003, Steen Lindkær-Jensen has left the board of directors of Renovaro Biosciences Denmark ApS.
As of January 7, 2002, Steen Sindet-Pedersen has left the board of directors of Renovaro Biosciences Denmark ApS.
As of June 22, 2001, REVISIONSKONTORET I AARHUS, AKTIESELSKAB has been appointed auditor of Renovaro Biosciences Denmark ApS.
As of June 22, 2001, JUT NR. 2180 A/S has stepped down as auditor of Renovaro Biosciences Denmark ApS.
As of June 22, 2001, Steen Lindkær-Jensen has joined the board of directors of Renovaro Biosciences Denmark ApS.
As of June 22, 2001, Mogens Trygve Lied Flagstad has joined the board of directors of Renovaro Biosciences Denmark ApS.
As of June 22, 2001, Steen Sindet-Pedersen has joined the board of directors of Renovaro Biosciences Denmark ApS.
As of June 22, 2001, Kim Madsen has left the board of directors of Renovaro Biosciences Denmark ApS.
As of June 22, 2001, Peter Andreas Stakemann has left the board of directors of Renovaro Biosciences Denmark ApS.
As of June 22, 2001, Annemette Heller has left the board of directors of Renovaro Biosciences Denmark ApS.
As of June 22, 2001, Suzanne Flagstad is registered as director of Renovaro Biosciences Denmark ApS.
As of June 22, 2001, Peter Andreas Stakemann has stepped down as director of Renovaro Biosciences Denmark ApS.
On June 22, 2001, the company changed its name from A/S PSE NR. 5697 to DANDRIT BIOTECH A/S.
As of April 1, 2001, JUT NR. 2180 A/S has been appointed auditor of Renovaro Biosciences Denmark ApS.
As of April 1, 2001, Kim Madsen has joined the board of directors of Renovaro Biosciences Denmark ApS.
As of April 1, 2001, Peter Andreas Stakemann has joined the board of directors of Renovaro Biosciences Denmark ApS.
As of April 1, 2001, Annemette Heller has joined the board of directors of Renovaro Biosciences Denmark ApS.
As of April 1, 2001, Peter Andreas Stakemann is registered as director of Renovaro Biosciences Denmark ApS.
Renovaro Biosciences Denmark ApS was founded on April 1, 2001.
Companies in the same industry and area
CVR 29691916
CVR 38579169
CVR 38046349
CVR 43134280
CVR 43855212
